Cellular and Humoral Responses to Myelin Basic Protein in Multiple Sclerosis: A Dichotomy

  • William Sheremata
  • Denise D. Woods
  • Mario A. Moscarello
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 100)


The macrophage migration inhibition factor (MIT) assay and a counterimmunodiffusion assay were utilized to measure immune responses to human myelin basic protein in 75 patients with multiple sclerosis (MS) and in 120 control subjects. Eight out of ten MS patients in acute exacerbation and one out of seventeen convalescent, but none of chronically ill MS patients gave positive results in the MIF test. Forty-six percent of the patients with negative NIF assays but only 22% of those with positive assays had positive antibody results. In the counterimmunodiffusion assay, myelin basic protein antibody was demonstrated in almost 2/3 of patients during convalescence but it was not present in those whose illness had been stable for 6 months or longer. While no correlation with the stage or duration of the illness was present in other disorders, in MS an inverse correlation with clinical activity and in vitro evidence of cellular sensitization to encephalitogenic basic protein was apparent.


Multiple Sclerosis Migration Inhibition Factor Myelin Basic Protein Optic Neuritis Experimental Allergic Encephalomyelitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bartfeld, H., Atoynatan, T. and Donnenfeld, H., In vitro cellular immunity to central nervous system antigens in multiple sclerosis, in Multiple Sclerosis: Immunology, Virology and Ultrastructure ( F. Wolfgram, G.W. Ellison, J.G. Stevens, J.M. Andrews, eds.) Academic Press, New York (1972) pp. 333–364.Google Scholar
  2. 2.
    Behan, P.O., Kies, M.W., Lisak, R.P. and Sheremata, W., Immunological mechanisms in experimental encephalomyelitis in nonhuman primates, Arch. Neurol. 29 (1973) 4–9.Google Scholar
  3. 3.
    Berg, 0. and Källen, B., Effect of mononuclear blood cells from multiple sclerosis patients of neuroglia in tissue culture, J. Neuropath. Exp. Neurol. 23 (1964) 550-559.Google Scholar
  4. 4.
    Bornstein, M.B. and Appel, S.H., Tissue culture studies of demyelination, Ann. N.Y. Acad. Sci. 122 (1965) 280–286.PubMedCrossRefGoogle Scholar
  5. 5.
    Brosman, C.F., Stoner, G.L., Bloom, B.R. and Wisniewski, H.M., Studies on demyelination by activated lymphocytes in the rabbit eye. Antibody-dependent cell-mediated demyelination, J. Immunol. 6 (1977) 2103–2110.Google Scholar
  6. 6.
    Colby, S., Sheremata, W., Bain, B. and Eylar, E.H., Cellular hypersensitivity in attacks of multiple sclerosis. A comparative study of MIF production and lymphoblastic transformation, Neurology 27 (1977) 132–139.Google Scholar
  7. 7.
    David, J.R. and Patterson, P.Y., In vitro demonstration of cellular sensitivity in allergic encephalomyelitis, J. Exp. Med. 122 (1965) 1161–1171.PubMedCrossRefGoogle Scholar
  8. 8.
    Eng, L.F., Choa, F.C., Gerstl, B., Pratt, D. and Tavaststjerna, M.G., The maturation of human white mutter myelin. Fractionation of the myelin membrane proteins, Biochem. 7 (1968) 4455–4465.CrossRefGoogle Scholar
  9. 9.
    Kies, M.W. and Alvord, E.C., Encephalitogenic activity in guinea pigs of water soluble protein fractions of nervous tissue, in Allergic encephalomyelitis ( M.W. Kies and E.C. Alvord, eds.) Thomas, Springfield (1959) pp. 293–299.Google Scholar
  10. 10.
    Lebar, R., Boutry, J.-M., Vincent, C., Robineaux, R. and Voisin, G.A., Studies on autoimmune encephalomyelitis in guinea pig. II. An in vitro investigation on the nature, properties and specificity of the serum-demyelinating factor, J. Immunol. 116 (1976) 1439.Google Scholar
  11. 11.
    Lisak, R.P., Heinze, R.G., Kies, M.W. and Alvord, E.C., Antibodies to encephalitogenic basic protein in experimental allergic encephalomyelitis, Proc. Soc. Exp. Biol. Med. 130 (1969) 814–818.PubMedGoogle Scholar
  12. 12.
    Lisak, R.P., Heinze, R.G., Falk, G.A. and Kies, M.W., Search for anti-encephalitogen antibody in human demyelinative disease, Neurology 18 (1968) 122–128.PubMedCrossRefGoogle Scholar
  13. 13.
    Lowden, J.A., Moscarello, M.A. and Morecki, R., The isolation and characterization of an acid-soluble protein from myelin, Can. J. Biochem. 44 (1966) 567–577.Google Scholar
  14. 14.
    Lumsden, C.E. Jr., The clinical pathology of multiple sclerosis, in Multiple Sclerosis. A reappraisal.(D. McAlpine, C.F. Lumsden, E.D. Acheson, eds.) Churchill-Livingstone, Edinburgh (1972) pp. 311–621.Google Scholar
  15. 15.
    MacKay, I.R., Carnegie, P.R. and Coates, A.S., Immunopathological comparisons between experimental autoimmune encephalomyelitis and multiple sclerosis, Clin. Exp. Immunol. 15 (1973) 471–482.Google Scholar
  16. 16.
    McPherson, T.A. and Carnegie, P.R., Radioimmunoassay with gel filtration for detecting antibody to basic proteins of myelin, J. Lab. Clin. Med. 72 (1968) 824–831.PubMedGoogle Scholar
  17. 17.
    McPherson, T.A., Liburd, E.M. and Seland, T.P., Binding of 125 I-labelled encephalitogenic basic protein to normal lymphocytes. Inhibition with multiple sclerosis serum. Clin. Exp. Immunol. 19 (1975) 451–458.Google Scholar
  18. 18.
    Offner, H., Clausen, J. and Fog, T., Precipitation of myelin basic protein by (3-lipoprotein of human serum, Acta Neurol. Scand. 50 (1974) 221–227.Google Scholar
  19. 19.
    Ouchterlony, 0., Diffusion-in-gel methods for immunological analysis, in Progress in Allergy, vol. 5 ( P. Kallos, ed.) Karger, Basel and New York (1958) pp. 1–78.CrossRefGoogle Scholar
  20. 20.
    Patterson, P.Y., Transfer of allergic encephalomyelitis in rats by means of lymph node cells, J. Exp. Med. 111 (1960) 119–136.CrossRefGoogle Scholar
  21. 21.
    Pekarek, J., Jedlicka, P. and Svejcar, J., Production of migration inhibitory factor by lymphocytes of patients with multiple sclerosis to brain antigens, Clin. Exp. Immunol., in pressGoogle Scholar
  22. 22.
    Rocklin, R.E., Meyers, 0.L. and David, J.R., An in vitro assay for cellular hypersensitivity in man, J. Immunol. 104 (1970) 95-102.Google Scholar
  23. 23.
    Rocklin, R.E., Sheremata, W., Feldman, R.G. et al., The Guillain-Barré syndrome and multiple sclerosis. In vitro cellular responses to nervous tissue antigens, . 284 (1971) 803–808.PubMedCrossRefGoogle Scholar
  24. 24.
    Sachs, H. and Steiner, G., Serologische Untersuchungen bei multipler Sklerose, Klin. Wochenschr. 13 (1934) 1714-1717.Google Scholar
  25. 25.
    Scheidegger, J.J., Une micro-méthode de 1’immuno-électrophorése, Int. Arch. Allergy Appl. Immunol. 7 (1955) 103–110.PubMedCrossRefGoogle Scholar
  26. 26.
    Schumacher, G.A., Beebe, G., Kibler, R.F., Kurland, L.T., Kurtzke, J.F., McDowell, F., Nagler, B., Sibley, W.A., Tourtellotte, W.W. and Willman, T.L., Problems of experimental trials in multiple sclerosis, Ann. N. Y. Acad. Sci. 122 (1965) 552–568.CrossRefGoogle Scholar
  27. 27.
    Seil, F.J., Falk, G.A., Kies, M.W. et al., The in vitro demyelinating activity of sera from guinea pigs sensitized with whole CNS and with purified encephalitogen, Exp. Neurol. 22 (1968) 545.Google Scholar
  28. 28.
    Sheremata, W., Cosgrove, J.B.R. and Eylar, E.H., Cellular hypersensitivity to basic myelin (A1) protein and clinical multiple sclerosis, N. Engl. J. Med. 291 (1974) 14–17.PubMedCrossRefGoogle Scholar
  29. 29.
    Sheremata, W., Wood, D.D., Moscarello, M.A. and Cosgrove, J.B.R., Multiole sclerosis: An inverse correlation between antibody and MIF production to myelin basic protein, J. Neurol. Sci., in press.Google Scholar
  30. 30.
    Wood, D.D., Orange, E.P. and Moscarello, M.A., The interaction of antibodies to two myelin proteins, Immunol. Commun.4 (1975) 17–27.Google Scholar

Copyright information

© Plenum Press, New York 1978

Authors and Affiliations

  • William Sheremata
    • 1
  • Denise D. Woods
    • 2
  • Mario A. Moscarello
    • 2
  1. 1.Montreal Neurological InstituteMontrealCanada
  2. 2.Research Unit, Sick Children’s HospitalUniversity of TorontoTorontoCanada

Personalised recommendations